Analyst expectations ^ (https://www.marketscreener.com/quote/stock/NANOSONICS-LIMITED-6499689/finances/)
Some projected numbers. Valuation is just a simple (NPAT x Multiple) + Cash, Nanosonics has no long term debt.
I'd expect Coris to contribute from FY26, wouldn't be a hard sell given hospitals are already cleaning endoscopes manually, if this is a superior method it's a no brainer from a risk mitigation perspective (And time / cost saving I'd imagine).If anyone has a view of the multiple NAN could sit at in 3 years time it would be much appreciated, I have been quite conservative also knowing Nanosonics fully expenses R&D.Obviously NAN will deserve a higher multiple if Coris is approved as it de-risks the business from 1 product to 2. I like the Printer & Ink style business model and deserves a premium over the market. Interested if anyone has a view around NAN conducting a share buy-back to deploy some of the spare cash (Assuming they aren't preparing for an acquisition).
From my rough numbers at the current price it's a decent risk/reward profile.
- Forums
- ASX - By Stock
- Ann: H2 FY24 Trading Update
Analyst expectations ^...
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.75 |
Change
-0.080(2.83%) |
Mkt cap ! $833.2M |
Open | High | Low | Value | Volume |
$2.82 | $2.83 | $2.75 | $2.969M | 1.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 27047 | $2.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.76 | 291 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 27047 | 2.750 |
4 | 6747 | 2.740 |
2 | 6498 | 2.730 |
3 | 2817 | 2.720 |
5 | 12619 | 2.710 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 291 | 1 |
2.770 | 410 | 1 |
2.780 | 6669 | 2 |
2.790 | 6669 | 2 |
2.800 | 9899 | 3 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |